LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer

References

• Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA: Cancer J Clin. 2014;64:9–29.
   PubMed Web of Science ®Google Scholar
• Bilusic M, Heery C, Madan RA. Immunotherapy in prostate cancer: emerging strategies against a formidable foe. Vaccine. 2011;29:6485–6497.10.1016/j.vaccine.2011.06.088
   PubMed Web of Science ®Google Scholar
• Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2012;62:220–241.10.3322/caac.v62:4
   PubMed Web of Science ®Google Scholar
• Xue G, Ren Z, Chen Y, et al. A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation. Cancer Lett. 2015;361:121–127.10.1016/j.canlet.2015.02.046
   PubMed Web of Science ®Google Scholar
• Roehl KA, Han M, Ramos CG, et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004;172:910–914.10.1097/01.ju.0000134888.22332.bb
   PubMed Web of Science ®Google Scholar
• Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177:2106–2131.10.1016/j.juro.2007.03.003
   PubMed Web of Science ®Google Scholar
• Boorjian SA, Eastham JA, Graefen M, et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Euro Urol. 2012;61:664–675.10.1016/j.eururo.2011.11.053
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159.10.1038/nrg2521
   PubMed Web of Science ®Google Scholar
• Harries L. Long non-coding RNAs and human disease. Biochem Soc Trans. 2012;40:902–906.10.1042/BST20120020
   PubMed Web of Science ®Google Scholar
• Spizzo R, Almeida MI, Colombatti A, et al. Long non-coding RNAs and cancer: a new frontier of translational research?. Oncogene. 2012;31:4577–4587.10.1038/onc.2011.621
   PubMed Web of Science ®Google Scholar
• Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113:1868–1874.10.1002/jcb.v113.6
   PubMed Web of Science ®Google Scholar
• Ellis BC, Molloy PL, Graham LD. CRNDE: a long non-coding RNA involved in cancer, neurobiology, and development. Front Genet. 2012;3:270. PMCID: PMC3509318. doi:10.3389/fgene.2012.00270.
   PubMedGoogle Scholar
• Martens-Uzunova ES, Böttcher R, Croce CM, et al. Long noncoding RNA in prostate, bladder, and kidney cancer. Euro Urol. 2014;65:1140–1151.10.1016/j.eururo.2013.12.003
   PubMed Web of Science ®Google Scholar
• X-y Fang, H-f Pan, R-x Leng, et al. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett. 2015;356:357–366.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhu Z, Zhang B, et al. Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer. J Genet Genom. 2014;41:187–195.10.1016/j.jgg.2014.03.006
   PubMed Web of Science ®Google Scholar
• Yang Y-R, Zang S-Z, Zhong C-L, et al. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7:6929–6935.
   PubMed Web of Science ®Google Scholar
• Ding C, Yang Z, Lv Z, et al. Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncol Lett. 2015;9:955–963.
   PubMed Web of Science ®Google Scholar
• Ding J, Li D, Gong M, et al. Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. OncoTargets Ther. 2014;7:1625–1630.10.2147/OTT
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Sawada G, Kurashige J, et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer. 2014;110:164–171.10.1038/bjc.2013.698
   PubMed Web of Science ®Google Scholar
• Guan Y, Kuo W-L, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007;13:5745–5755.10.1158/1078-0432.CCR-06-2882
   PubMed Web of Science ®Google Scholar
• Soubra A, Konety B, Bagchi A. MP61-06 increased PVT1 expression correlates with advanced stage and hormone resistance of prostate cancer. J Urol. 2015;193:e748–e749.10.1016/j.juro.2015.02.2187
   Web of Science ®Google Scholar
• Meyer KB, Maia A-T, O’Reilly M, et al. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genet. 2011;7:e1002165.10.1371/journal.pgen.1002165
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu X, Ou L, et al. PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor. Cancer Lett. 2015;362:61–69.
   PubMed Web of Science ®Google Scholar
• Ummanni R, Lehnigk U, Zimmermann U, et al. Immunohistochemical expression of caspase-1 and -9, uncleaved caspase-3 and -6, cleaved caspase-3 and -6 as well as Bcl-2 in benign epithelium and cancer of the prostate. Exp Ther Med. 2010;1:47–52.10.3892/etm_00000008
   PubMed Web of Science ®Google Scholar
• Guo K, Yao J, Yu Q, et al. The expression pattern of long non-coding RNA PVT1 in tumor tissues and in extracellular vesicles of colorectal cancer correlates with cancer progression. Tumour Biol J Int Soc Oncodev Biol Med. 2017;39:1010428317699122.
   Google Scholar
• Liu HT, Fang L, Cheng YX, et al. LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a. Cancer Med. 2016;5:3512–3519.10.1002/cam4.900
   PubMed Web of Science ®Google Scholar
• Peng J, Huang F, Zhuang Y, et al. Effect of LncRNA-PVT1 on proliferation and apoptosis of human pancreatic cancer cell line HPAF-Ⅱ. Chin J Gastroenterol. 2016;21:138–143.
   Google Scholar
• Riquelme E, Suraokar MB, Rodriguez J, et al. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma. J Thorac Oncol. 2014;9:998–1007.10.1097/JTO.0000000000000202
   PubMed Web of Science ®Google Scholar
• Srikantan V, Zou Z, Petrovics G, et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Nat Acad Sci. 2000;97:12216–12221.10.1073/pnas.97.22.12216
   PubMed Web of Science ®Google Scholar
• Petrovics G, Zhang W, Makarem M, et al. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene. 2004;23:605–611.10.1038/sj.onc.1207069
   PubMed Web of Science ®Google Scholar